Institute for Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, 58 Turner Street, London, E1 2AB, UK.
Newcastle upon Tyne NHS Hospitals Foundation Trust, Chest Clinic, New Victoria Wing RVI Hospital, Queen Victoria Road, Newcastle upon Tyne, NE1 4LP, UK.
Trials. 2021 Apr 6;22(1):252. doi: 10.1186/s13063-021-05203-x.
Guidelines now call for a thorough and comprehensive description of the development of healthcare interventions to aid evaluation and understanding of the processes of change. This was the primary aim of this study but we also recognised that effective interventions are commonly not implemented in clinical practice. It is suggested that insufficient attention is given to the implementation process at the development phase of interventions. This study outlines the 5 step iterative process we adopted for considering both implementation and effectiveness issues from the outset of intervention development. We use the development of a complex intervention Tailored intervention for ANxiety and DEpression Management (TANDEM) in patients with chronic obstructive pulmonary disease to illustrate this process.
Intervention development built upon the Medical Research Council framework for developing complex interventions and the person-based approach for development of behavioural interventions. Building an expert team, specifying theory, qualitative data collection and pre-piloting were all critical steps in our intervention development and are described here.
Contact with experts in the field, and explicitly building on previous work, ensured efficiency of design. Qualitative work suggested guiding principles for the intervention such as introducing mood in relation to breathlessness, and providing flexible tailoring to patients' needs, whilst implementation principles focused on training selected respiratory professionals and requiring supervision to ensure standards of care. Subsequent steps of intervention development, pre-piloting and intervention refinement led to an intervention that was deemed acceptable and if successful will be ready for implementation.
The TANDEM study was developed efficiently by building on previous work and considering implementation issues from the outset, with the aim that if shown to be effective it will have more rapid translation in to the health care system with accelerated patient benefits.
ISRCTN ISRCTN59537391 . Registered on 20 March 2017. Protocol version 6.0, 22 April 2018.
指南现在呼吁对医疗干预措施的发展进行彻底和全面的描述,以帮助评估和理解变革过程。这是本研究的主要目的,但我们也认识到有效的干预措施通常在临床实践中没有得到实施。有人认为,在干预措施的开发阶段,对实施过程的关注不够。本研究概述了我们在干预措施开发的初始阶段就采用的 5 步迭代过程,以同时考虑实施和有效性问题。我们使用慢性阻塞性肺疾病患者的复杂干预措施——量身定制的焦虑和抑郁管理干预措施(TANDEM)的开发来说明这一过程。
干预措施的开发是基于医疗研究委员会开发复杂干预措施的框架和行为干预措施的人本方法。组建一个专家团队、明确理论、进行定性数据收集和预试验都是我们干预措施开发中的关键步骤,这里都有描述。
与该领域专家的联系,以及明确借鉴以前的工作,确保了设计的效率。定性工作为干预措施提出了指导原则,例如将情绪与呼吸困难联系起来,并根据患者的需求提供灵活的定制,而实施原则则侧重于培训选定的呼吸专业人员,并要求监督以确保护理标准。随后的干预措施开发步骤,预试验和干预措施的改进导致了一种被认为是可接受的干预措施,如果成功,它将更快地在医疗保健系统中实施,从而更快地使患者受益。
TANDEM 研究通过借鉴以前的工作并从一开始就考虑实施问题,高效地进行了开发,目的是如果证明有效,它将更快地转化为医疗保健系统,加速患者获益。
ISRCTN ISRCTN59537391。于 2017 年 3 月 20 日注册。协议版本 6.0,2018 年 4 月 22 日。